Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aminolevulinic acid hydrochloride by Photonamic for Meningioma: Likelihood of Approval
Aminolevulinic acid hydrochloride is under clinical development by Photonamic and currently in Phase III for Meningioma. According to GlobalData, Phase...
Aminolevulinic acid hydrochloride by Biofrontera for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
Aminolevulinic acid hydrochloride is under clinical development by Biofrontera and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC)....
Aminolevulinic acid hydrochloride by Photonamic for Colorectal Cancer: Likelihood of Approval
Aminolevulinic acid hydrochloride is under clinical development by Photonamic and currently in Phase II for Colorectal Cancer. According to GlobalData,...
Aminolevulinic acid hydrochloride by Photonamic for Ovarian Cancer: Likelihood of Approval
Aminolevulinic acid hydrochloride is under clinical development by Photonamic and currently in Phase III for Ovarian Cancer. According to GlobalData,...